Skip to main content
SLSBio(Specialty Lab Solution Bio) Co., Ltd logo

SLSBio(Specialty Lab Solution Bio) Co., Ltd — Investor Relations & Filings

Ticker · 246250 ISIN · KR7246250005 KO Professional, scientific and technical activities
Open in API
Filings indexed 261 across all filing types
Latest filing 2023-08-21 Share Issue/Capital Cha…
Country KR South Korea
Listing KO 246250

About SLSBio(Specialty Lab Solution Bio) Co., Ltd

http://www.slabs.co.kr/

SLSBio (Specialty Lab Solution Bio) Co., Ltd. is a company specializing in laboratory solutions and support services for the pharmaceutical and biotechnology sectors. Its primary offerings include pharmaceutical quality control testing, clinical trial sample analysis, bioequivalence studies, drug stability testing, and new drug development support. In addition to its service portfolio, the company develops and manufactures diagnostic technologies, reagents, and other biological agents, supporting various stages of the drug development and commercialization lifecycle.

Recent filings

Filing Released Lang Actions
주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matters Report' (주요사항보고서) filed with the Financial Services Commission in South Korea regarding a decision for a paid-in capital increase (유상증자결정) for an IPO (initial public offering) on the KOSDAQ market. It details the number of shares, offering price, subscription dates, and the role of the lead underwriter (Hana Securities). This type of regulatory filing for capital changes and share issuance falls under the 'Share Issue/Capital Change' category.
2023-08-21 Korean
[기재정정]주요사항보고서(유상증자결정)
Share Issue/Capital Change Classification · 100% confidence The document is a 'Major Matter Report' (주요사항보고서) regarding a 'Decision on Paid-in Capital Increase' (유상증자결정) for the company SLS Bio. It details the issuance of new shares, the purpose of the funds, the subscription schedule, and the underwriting process. This is a formal regulatory filing related to capital structure changes and share issuance, which falls under the 'Share Issue/Capital Change' category.
2023-08-21 Korean
증권신고서(지분증권) (2023.09)
Share Issue/Capital Change Classification · 95% confidence The document is a '증권신고서' (Securities Registration Statement) filed by '주식회사 에스엘에스바이오' (SLS Bio) with the Financial Services Commission (FSC) of South Korea. It contains detailed information regarding a public offering of shares, including investment risks, business descriptions, and financial disclosures. This document is a formal regulatory filing required for public offerings, which falls under the 'Regulatory Filings' category as it is a primary legal document for securities registration.
2023-08-18 Korean
특허권취득(자율공시)
Regulatory Filings Classification · 100% confidence The document is a short, voluntary disclosure (자율공시) regarding the acquisition of a patent by SLS Bio. It does not fit into financial reporting categories like 10-K or IR, nor does it represent a corporate action like a dividend or share buyback. As it is a regulatory announcement of a specific corporate event (patent acquisition) that does not fall into the other specialized categories, it is classified as a general regulatory filing.
2023-08-16 Korean
기타주요경영사항(자율공시)(코스닥시장 상장예비심사 승인)
Regulatory Filings Classification · 100% confidence The document is a short regulatory announcement from SLS Bio regarding the approval of their preliminary review for listing on the KOSDAQ market. It is a voluntary disclosure (자율공시) of a corporate event rather than a financial report, audit, or proxy statement. Since it does not fit into specific categories like M&A or share issuance, and serves as a general regulatory update, it falls under the RNS (Regulatory Filings) category.
2023-06-29 Korean
기타주요경영사항(자율공시)(코스닥시장 상장을 위한 상장예비심사 청구)
Regulatory Filings Classification · 100% confidence The document is a short regulatory announcement (606 characters) regarding a company's filing for a preliminary review for KOSDAQ market listing. It does not contain full financial statements or a comprehensive report, but rather serves as a notification of a corporate action (listing process). As it is a regulatory disclosure of a specific event that does not fit into the other specialized categories like M&A or Share Issues, it is classified as a general regulatory filing.
2023-04-20 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.